Shinhan Financial's Lotte Insurance Acquisition Collapses, Shifts to Open Auction

Lotte Non-Life Insurance's sale has shifted to an open auction process following the final breakdown of negotiations with preferred bidder Shinhan Financial Group. Shinhan Financial reportedly abandoned its acquisition pursuit after roughly one month of exclusive talks, unable to bridge differences over enterprise value (EV).

According to investment banking (IB) industry sources on the 30th, Shinhan Financial Group has effectively withdrawn from the bidding for Lotte Non-Life Insurance. JKL Partners, Lotte Non-Life Insurance's largest shareholder, had appointed Samjong KPMG as lead manager earlier this year to pursue a controlling stake sale. While Shinhan Financial showed strong acquisition interest that led to exclusive negotiations, the group ultimately could not overcome capital adequacy concerns and the price gap.

The decisive obstacle in the negotiations was Shinhan Financial's capital adequacy management burden. In April, Shinhan Financial outlined a blueprint through its "Value-Up 2.0" policy to maintain its Common Equity Tier 1 (CET1) ratio at 13.0–13.4%. Increased equity investments in other entities through M&A would raise risk-weighted assets (RWA), pressuring this ratio. While Shinhan Financial had spending capacity within ₩1 trillion (approximately $703.1 million), JKL Partners reportedly demanded a higher enterprise value, revealing a significant gap in expectations.

JKL Partners' desired sale price was reportedly around ₩1 trillion. JKL Partners acquired a 77.04% controlling stake in Lotte Non-Life Insurance from Lotte Group in 2019 for ₩373.4 billion (approximately $262.5 million), and subsequently participated in a ₩356.2 billion (approximately $250.4 million) rights offering. With roughly ₩730 billion (approximately $513.2 million) deployed between the acquisition and capital injection, recovering the investment requires at least that amount or more.

However, the market views Lotte Non-Life Insurance's fair acquisition price at ₩700 billion to ₩800 billion. An IB industry official noted, "Typically, insurance company valuations are based on a price-to-book ratio (PBR) of 1x, assuming no major asset quality issues. Working backwards from Lotte Non-Life Insurance's current market capitalization, around ₩700 billion appears to be a reasonable price."

Post-acquisition additional capital burdens also weighed on price negotiations. Lotte Non-Life Insurance's basic capital solvency ratio stood at negative 24% in the first quarter of this year. Starting next year, South Korean insurers must maintain a basic capital ratio above 50% under new regulations, requiring at least ₩1 trillion in phased additional capital injections to meet this threshold. Furthermore, subordinated bonds issued between 2020 and 2024 total ₩810 billion (approximately $569.5 million), adding repayment or refinancing pressure as maturities and call options approach. IB industry estimates suggest approximately ₩2 trillion in capital injections will be unavoidable within three to five years post-acquisition.

That said, Lotte Non-Life Insurance's financial soundness indicators have been improving recently. Its solvency ratio (K-ICS) rose from 119.9% in the first quarter of last year to a provisional 159.3% at year-end, surpassing the financial authorities' recommended threshold of 130%. This improvement stems from shifting the asset portfolio—previously concentrated in alternative investments—toward safe assets like bonds. Net profit last year reached ₩51.3 billion (approximately $36.1 million), up 111.9% from 2024, while the contractual service margin (CSM), a forward-looking profitability indicator, stood at ₩2.47 trillion (approximately $1.7 billion) at year-end, a 6.7% increase from ₩2.32 trillion (approximately $1.6 billion) at end-2024.

For the upcoming open auction to succeed, tailored strategies for each financial holding company will likely be necessary. Potential bidders currently mentioned include financial holding companies with no or weak non-life insurance portfolios. Korea Investment Holdings has bid on multiple insurance M&A deals this year, while Woori Financial Group and BNK Financial Group—both with relatively weaker non-bank business segments—are also in the candidate pool. Additionally, securities firms such as Mirae Asset Securities and Kiwoom Securities, which could strengthen their IB operations using insurance assets, are expected to show interest.

Domestic and international financial firms have maximized non-life insurer acquisition benefits through varying strategies. KB Financial Group acquired LIG Non-Life Insurance (now KB Non-Life Insurance) in 2015 and rose to industry leadership by leveraging KB Kookmin Bank's offline distribution channels for bancassurance and combined banking-insurance products. Meritz Financial Group achieved rapid growth by utilizing Meritz Fire & Marine Insurance's low-interest insurance liabilities for its IB business.

An insurance industry source commented, "For financial holding companies where banking is the core business, bancassurance—combined banking and insurance products—is key. For those where securities is the core, utilizing low-interest insurance liabilities is critical. The synergies sought through acquisition will differ by holding company."

An IB industry official forecast, "Establishing a new non-life insurer requires stringent regulatory approval and entails significant upfront expenditure. Acquiring an existing non-life insurer can be advantageous, and given the limited availability of large non-life insurance targets, there should be considerable interest from potential buyers."